How do psychiatrists choose among different antipsychotics?

European Journal of Clinical Pharmacology

Volumn 61, Issue 11, 2005, Pages 851-854

  Hamann, Johannes ^a,b   Kolbe, Grit ^a   Cohen, Rudolf ^a   Leucht, Stefan ^a   Kissling, Werner ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; DRUG CHOICE; DRUG EFFICACY; FEMALE; GERMANY; HOSPITAL PATIENT; HUMAN; INTERVIEW; MALE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; SCHIZOPHRENIA; SYMPTOM; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; DECISION MAKING; FEMALE; GERMANY; HUMANS; INTERVIEWS; MALE; PHARMACOEPIDEMIOLOGY; PHYSICIAN'S PRACTICE PATTERNS; PSYCHIATRY; SCHIZOPHRENIA;

EID: 28344437241     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0041-7     Document Type: Article

References (11)

1. Hamann J, Langer B, Leucht S, Busch R, Kissling W (2004) Medical decision making in antipsychotic drug choice for schizophrenia. Am J Psychiatry 161:1301-1304
2. Ren XS, Kazis LE, Lee AF, Huang YH, Hamed A, Cunningham F, Herz L, Miller DR (2005) Patient characteristics and the likelihood of initiation on olanzapine or risperidone among patients with schizophrenia. Schizophrenia Res (in press)
3. Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J (2004) Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 161(Suppl 1):1-56
4. Riedel M, Strassnig M, Muller N, Zwack P, Moller HJ (2005) How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials? Eur Arch Psychiatry Clin Neurosci 255:143-148
5. National Institute for Clinical Excellence (2002) Clinical guideline 1: schizophrenia
6. Corry P, Hogman G, Sandamas G (2001) That's just typical. National Schizophrenia Fellowship, London
7. Hamann J, Leucht S, Kissling W (2003) Shared decision making in psychiatry. Acta Psychiatr Scand 107:403-409
8. Davis JM, Chen N, Glick ID (2003) A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 60:553-564
9. Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S (2003) Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 60:82-91
10. Prosser H, Almond S, Wallay T (2002) Influences on GPs' decisions to prescribe new drugs - the importance of who says what. Fam Pract 20:61-68
11. Zimmerman M, Posternak M, Friedman M, Attiullah N, Baymiller S, Boland R, Berlowitz S, Rahman S, Uy K, Singer S (2004) Which factors influence psychiatrists' selection of antidepressants? Am J Psychiatry 161:1285-1289